BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 227998)

  • 1. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
    Maheshwari RK; Jay FT; Friedman RM
    Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity.
    Maheshwari RK; Friedman RM
    Virology; 1980 Mar; 101(2):399-407. PubMed ID: 6244697
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell killing by viruses. III. The interferon system and inhibition of cell killing by vesicular stomatitis virus.
    Marcus PI; Sekellick MJ
    Virology; 1976 Feb; 69(2):378-93. PubMed ID: 176779
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of vesicular stomatitis virus by kethoxal bis (thiosemicarbazone).
    Levinson W; Oppermann H; Jackson J
    J Gen Virol; 1977 Oct; 37(1):183-90. PubMed ID: 72131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response.
    Ostertag D; Hoblitzell-Ostertag TM; Perrault J
    J Virol; 2007 Jan; 81(2):503-13. PubMed ID: 17065213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
    Allen PT; Schellekens H; Van Griensven LJ; Billiau A
    J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interferon on transcription and translation of vesicular stomatitis virus in human and simian cell cultures.
    Thacore HR
    J Gen Virol; 1978 Nov; 41(2):421-6. PubMed ID: 214523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and biochemical characterization of vesicular stomatitis virus with low infectivity released from interferon treated cells.
    Maheshwari RK; Friedman RM
    Uttar Pradesh State Dent J; 1980 Jul; 11(3):95-110. PubMed ID: 6159713
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon treatment inhibits glycosylation of a viral protein.
    Maheshwari RK; Banerjee DK; Waechter CJ; Olden K; Friedman RM
    Nature; 1980 Oct; 287(5781):454-6. PubMed ID: 6159539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interferon on vesicular stomatitis virus transcription and translation.
    Baxt B; Sonnabend JA; Bablanian R
    J Gen Virol; 1977 May; 35(2):325-34. PubMed ID: 195009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of RNA and protein synthesis in interferon-treated HeLa cells infected with vesicular stomatitis virus.
    Simili M; de Ferra F; Baglioni C
    J Gen Virol; 1980 Apr; 47(2):373-84. PubMed ID: 6154130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA synthesis by vesicular stomatitis virus and a small plaque mutant: effects of cycloheximide.
    Wertz GW; Levine M
    J Virol; 1973 Aug; 12(2):253-64. PubMed ID: 4355930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of vesicular stomatitis virus in interferon-treated cell cultures.
    Thacore HR; Youngner JS
    Virology; 1975 Feb; 63(2):345-51. PubMed ID: 163524
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of vesicular stomatitis virus multiplication in Vero cells by 2-deoxy-D-glucose.
    Sabina LR; Telasco CE
    Acta Virol; 1979 May; 23(3):210-20. PubMed ID: 41433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus.
    Perrault J; Holland JJ
    Virology; 1972 Oct; 50(1):150-70. PubMed ID: 4343109
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of interferon inhibition of viruses that bud from the plasma membrane.
    Friedman RM; Maheshwari RK; Jay FT; Czarniecki C
    Ann N Y Acad Sci; 1980; 350():533-44. PubMed ID: 6165302
    [No Abstract]   [Full Text] [Related]  

  • 19. The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication.
    Hoshino M; Taira H; Hattori S; Kawakita M
    J Biochem; 1987 Mar; 101(3):685-94. PubMed ID: 2439495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.